AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9142771
Drug: Extended-interval dosing
RxNorm normalized name: Minerval
DrugBank: Idroxioleic acid (DB18213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-interval dosing of aminoglycosides
Trial: 8457446
Drug: Non-steroidal anti-inflammatory
RxNorm normalized name: Non-steroidal anti-inflammatory agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-steroidal anti-inflammatory drug (indomethacin)
Trial: 8457446
Drug: Antihistamine (diphenhydramine)
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihistamine (diphenhydramine)
Trial: 12372721
Drug: Adjuvant systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant systemic chemotherapy
Trial: 26162850
Drug: GVXN SD133
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GVXN SD133 vaccine (2 μg with or without aluminium adjuvant)
Trial: 26162850
Drug: GVXN SD133
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GVXN SD133 vaccine (10 μg with or without aluminium adjuvant)
Trial: 26162850
Drug: GVXN SD133
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GVXN SD133 vaccine (2 μg or 10 μg)
Trial: 16939923
Drug: remifentanil by
FDA approved: no
EMA approved: no
PMDA approved: no
Description: remifentanil by TCI, propofol, and doxapram 0.6 mg/kg
Trial: 8263313
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg venlafaxine
Trial: 8263313
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg venlafaxine
Trial: 1389931
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of venlafaxine
Trial: 26828426
Drug: Progressive resistance-training
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Progressive resistance-training intervention during radiation treatment
Trial: 26828426
Drug: Progressive resistance-training
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Progressive resistance-training intervention after radiation treatment
Trial: 3322096
Drug: i.v. meptazinol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. meptazinol 2 mg/kg
Trial: 3322096
Drug: i.v. meptazinol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. meptazinol 4 mg/kg
Trial: 28196208
Drug: Single 8-Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 8-Gy radiotherapy dose for 1 or 2 bone metastases
Trial: 12376849
Drug: Propofol (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (0.6 mg/kg)
Trial: 12376849
Drug: Ketamin (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamin (0.6 mg/kg)
Trial: 7488690
Drug: Hypocaloric diet
RxNorm normalized name: Hydrochloric Acid
DrugBank: Hydrochloric acid (DB13366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypocaloric diet plus serotoninergic medication
Trial: 21406694
Drug: Emollient cream
RxNorm normalized name: EMOLLIENT CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emollient cream
Trial: 6257799
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (placebo preparation)
Trial: 7128190
Drug: Placebo oral
RxNorm normalized name: placebo ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo oral rinse
Trial: 24970720
Drug: iCBT group‐therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iCBT group‐therapy format (iCBT‐G)
Trial: 16316359
Drug: Oral paricalcitol
RxNorm normalized name: Paricalcitol
DrugBank: Paricalcitol (DB00910)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral paricalcitol
Trial: 14963679
Drug: Evidence-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based treatment in cooperation with general practitioner (GP).
Trial: 9602583
Drug: HBOC‐201 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBOC‐201 0.4 g kg‐1
Trial: 9602583
Drug: HES 3
RxNorm normalized name: TELFA PAD NON-ADHES 3IN X 8IN NONSTERILE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HES 3 ml kg‐1
Trial: 909027
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of povidone iodine on umbilical cord and normal intact skin
Trial: 909027
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of povidone iodine on denuded skin
Trial: 909027
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of povidone iodine
Trial: 30978622
Drug: Prolonged Exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged Exposure Therapy (PE) and Relaxation Training (RT)
Trial: 1447501
Drug: Sodium fluoride
RxNorm normalized name: Sodium Fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium fluoride (50 mg/day)
Trial: 20060078
Drug: teriparatide 20
RxNorm normalized name: TERIPARATIDE 200UNT/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: teriparatide 20 mug/day by subcutaneous injection
Trial: 20060078
Drug: alendronate 10
RxNorm normalized name: ALENDRONATE 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alendronate 10 mg/day orally
Trial: 6137468
Drug: Pindolol (beta-adrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (beta-adrenergic antagonist)
Trial: 22578834
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose CTCA using FBP (protocol A)
Trial: 16645456
Drug: Inhalation anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation anesthesia
Trial: 1595776
Drug: Insulin plus
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin plus 10 mg glyburide before breakfast
Trial: 1595776
Drug: Insulin-only group
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-only group
Trial: 3967459
Drug: Propranolol (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (240 mg/day after 3 weeks)
Trial: 3967459
Drug: Nadolol (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol (240 mg/day after 3 weeks)
Trial: 28195139
Drug: MDMA-HCl (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDMA-HCl (100 mg p.o.)
Trial: 21849603
Drug: Higher protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher protein (HP; 2.9 and 4.4 g protein/100 kcal)
Trial: 21849603
Drug: Lower protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower protein (LP; 1.77 and 2.2 g protein/100 kcal)
Trial: 20169858
Drug: Levocetirizine dihydrochloride
RxNorm normalized name: Levocetirizine Dihydrochloride
DrugBank: Levocetirizine (DB06282)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levocetirizine dihydrochloride orally disintegrating tablets with Indion‐204 as taste-masking agent
Trial: 20169858
Drug: Levocetirizine dihydrochloride
RxNorm normalized name: Levocetirizine Dihydrochloride
DrugBank: Levocetirizine (DB06282)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levocetirizine dihydrochloride orally disintegrating tablets with Tulsion‐335 as taste-masking agent
Trial: 20169858
Drug: Levocetirizine dihydrochloride
RxNorm normalized name: Levocetirizine Dihydrochloride
DrugBank: Levocetirizine (DB06282)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levocetirizine dihydrochloride orally disintegrating tablets with crospovidone as superdisintegrant
Trial: 20169858
Drug: Optimum formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimum formulation (F‐1) of levocetirizine dihydrochloride orally disintegrating tablets
Trial: 17944177
Drug: Tretinoin gel
RxNorm normalized name: Tretinoin Gel
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tretinoin gel microsphere 0.04%
Trial: 14622808
Drug: Standardized exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized exercise therapy with functional electrical muscle stimulation
Trial: 10647762
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (tinzaparin sodium)
Trial: 28562168
Drug: Tacrolimus (TAC)
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus (TAC) monotherapy at an initial dose of 0.05-0.1 mg/kg/day
Trial: 28562168
Drug: Tacrolimus (TAC)
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus (TAC) monotherapy
Trial: 21543239
Drug: High-dose zonisamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose zonisamide (6-8 mg/kg/day)
Trial: 2982538
Drug: Adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline infusion with intra-arterial propranolol
Trial: 2982538
Drug: Noradrenaline infusion
RxNorm normalized name: noradrenaline hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noradrenaline infusion with intra-arterial propranolol
Trial: 2982538
Drug: Doxazosin infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin infusion
Trial: 8274583
Drug: Yohimbine infusion
RxNorm normalized name: YOHIMBINE
DrugBank: Yohimbine (DB01392)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine infusion
Trial: 27511182
Drug: Interferon beta‐1b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon beta‐1b (early treatment)
Trial: 10743799
Drug: Placebo (delayed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (delayed treatment)
Trial: 24361086
Drug: Subcutaneous diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous diclofenac HPbCD administered in gluteus
Trial: 24361086
Drug: Subcutaneous diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous diclofenac HPbCD administered in abdomen
Trial: 20369059
Drug: MF59-adjuvanted influenza
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted influenza vaccine (Sub/MF59)
Trial: 17197592
Drug: No injection
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No injection
Trial: 2207852
Drug: Sanguinaria toothpaste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sanguinaria toothpaste and oral rinse regimen
Trial: 9769395
Drug: Arm B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm B: IFO 1.5 g/m2 i.v. as a 4 h infusion on days 1-5, Mesna 600 mg i.v. as push injection at 0 h, 4 h, 8 h on days 1-5, CDDP 20 mg i.v. as a 60 min infusion on days 1-5, repeated every 28 days for 3 cycles.
Trial: 7918930
Drug: Flumecinol 600
RxNorm normalized name: Flumecinol
DrugBank: Flumecinol (DB18178)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumecinol 600 mg once weekly for 3 weeks
Trial: 7918930
Drug: Flumecinol 300
RxNorm normalized name: Flumecinol
DrugBank: Flumecinol (DB18178)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumecinol 300 mg daily for 3 weeks
Trial: 8460757
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% with adrenaline (15 ml) administered by lumbar epidural injection 15 min before surgery (group A)
Trial: 8460757
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% with adrenaline (15 ml) administered at the end of surgery (group B)
Trial: 24928286
Drug: Intravenous diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diazepam (DZP‐IV)
Trial: 24928286
Drug: Intramuscular midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular midazolam (MDZ‐IM)
Trial: 24145678
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron sulfate (113 patients)
Trial: 17935921
Drug: Transarterial infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transarterial infusion (TAI) with water-in-oil-in-water (W/O/W) emulsion containing epirubicin
Trial: 10898131
Drug: Ciprofloxacin 250
RxNorm normalized name: ciprofloxacin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 250 mg b.i.d.
Trial: 2218422
Drug: Ofloxacin 200
RxNorm normalized name: ofloxacin 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin 200 mg b.i.d.
Trial: 8996854
Drug: Voltaren (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voltaren (100 mg tablets)
Trial: 8875584
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg terbutaline sulfate
Trial: 6364906
Drug: 0.25 ml
RxNorm normalized name: mineral oil 0.25 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 ml normal saline solution (placebo)
Trial: 25528281
Drug: CST in
RxNorm normalized name: dimethiconol (50000 CST)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CST in combination with acetylcholinesterase inhibitors (ACHEIs)
Trial: 23624802
Drug: pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: pegylated interferon alpha‐2b (PEG‐IFNα‐2b) therapy
Trial: 24638207
Drug: Lozenges without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lozenges without added probiotics (control group)
Trial: 3664426
Drug: Tamoxifen (TAM)
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen (TAM) 10 mg to 20 mg twice orally
Trial: 26259978
Drug: Jet injection
RxNorm normalized name: Jet Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jet injection of insulin aspart
Trial: 28303726
Drug: Conventional pen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional pen administration of insulin aspart
Trial: 18781134
Drug: Vindesine treatment
RxNorm normalized name: vindesine
DrugBank: Vindesine (DB00309)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vindesine treatment for 2 years
Trial: 12944243
Drug: Amrinone 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amrinone 1.5 mg/kg plus 10 microg/kg/min infusion for 10 hours
Trial: 23461581
Drug: Intrathecal immunoglobulin
RxNorm normalized name: immunoglobulin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal immunoglobulin (1000 IU, free of preservatives) plus intramuscular immunoglobulin (3000 IU)
Trial: 23461581
Drug: Intramuscular immunoglobulin
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular immunoglobulin (3000 IU, with preservative)
Trial: 19760991
Drug: Proton Pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton Pump Inhibitor (PPI) Group
Trial: 16572922
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg tablet formulation
Trial: 10831943
Drug: Phytoestrogens (PE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phytoestrogens (PE) 80 mg/day of isoflavones
Trial: 8221449
Drug: PRP‐T vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP‐T vaccine mixed with DPT vaccine (combined in one injection)
Trial: 8221449
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (PRP‐T and DPT vaccines)
Trial: 8221449
Drug: PRP‐T vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP‐T vaccine mixed with DPT vaccine
Trial: 22411483
Drug: Clonidine 150
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine 150 μg
Trial: 31213063
Drug: Cognitive behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behaviour therapy targeting emotion regulation
Trial: 31213063
Drug: Pre-treatment levels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-treatment levels of parent and child-reported emotion regulation
Trial: 24938224
Drug: Flaxseed (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed (30 g of milled flaxseed per day for six months)
Trial: 22643948
Drug: Topical steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical steroid drops applied with the Mygind technique for 8 weeks postoperatively
Trial: 22643948
Drug: Topical steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical steroid sprays for 8 weeks postoperatively
Trial: 18640074
Drug: Flexible-dose pregabalin
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Flexible-dose pregabalin (150-600 mg/d)
Trial: 18640074
Drug: Fixed-dose pregabalin
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Fixed-dose pregabalin (300 mg/d)
Trial: 18640074
Drug: Flexible-dose pregabalin
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Flexible-dose pregabalin
Trial: 18640074
Drug: Fixed-dose pregabalin
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Fixed-dose pregabalin
Trial: 10556869
Drug: 40/50 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40/50 mg metrifonate
Trial: 1579337
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg ticlopidine b.i.d. (49 patients)
Trial: 27182847
Drug: Self-management occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-management occupational therapy intervention program (SMOoTh)
Trial: 30305890
Drug: Goal-Directed Fluid
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-Directed Fluid Therapy (GDFT)
Trial: 23301466
Drug: Electroacupuncture +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture + medication
Trial: 23301466
Drug: Conventional acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional acupuncture + medication
Trial: 23301466
Drug: Medication (seroxat)
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (seroxat)
Trial: 18215590
Drug: Both Aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both Aspirin and Tranexamic Acid
Trial: 12730088
Drug: naproxen (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen (1000 mg/d)
Trial: 12730088
Drug: aspirin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aspirin (75 mg/d)
Trial: 12730088
Drug: diclofenac (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac (150 mg/d)
Trial: 1801542
Drug: deprenyl, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: deprenyl, 10 mg/day
Trial: 7047649
Drug: Gentamycin (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamycin (single injection one hour before surgery)
Trial: 7047649
Drug: Untreated group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Untreated group (no antibiotic)
Trial: 22583135
Drug: Drug provocation
RxNorm normalized name: OCTINOXATE 0.072 g in 1 g TOPICAL LIPSTICK [EFFET PARFAIT ROUGE AMPLIFIER AMPLIFYING SPF 15 (ROUGE PROVOCATION) - RED]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug provocation test (DPT)
Trial: 11908467
Drug: Tibolone 2.5
RxNorm normalized name: tibolone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone 2.5 mg once daily for 8 weeks
Trial: 10456811
Drug: Metoclopramid (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramid (10 mg i.v. bolus during dopamine infusion)
Trial: 8834935
Drug: Zolpidem 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem 15 mg
Trial: 2475056
Drug: Intramuscular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular therapy with vitamin D (600,000 IU)
Trial: 19143855
Drug: Lumiracoxib 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumiracoxib 400 mg once daily (qd)
Trial: 19143855
Drug: Naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 500 mg twice daily (bid)
Trial: 17166990
Drug: Fixed-dose budesonide
RxNorm normalized name: budesonide Metered Dose Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose budesonide (320 microg qd)
Trial: 17166990
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination (budesonide/formoterol 80/4.5 microg qd)
Trial: 10809032
Drug: Azithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (500 mg once daily intravenously followed by 500 mg once daily orally)
Trial: 10809032
Drug: Cefuroxime plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime plus erythromycin (750 mg every 8 hours intravenously followed by 500 mg twice daily orally for cefuroxime and 500-1000 mg every 6 hours for erythromycin)
Trial: 28974835
Drug: Surgical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical therapy with bone replacement material (group 2)
Trial: 28974835
Drug: Surgical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical therapy without bone replacement material (group 1)
Trial: 1592346
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (600 mg/day)